Tags
Blog

'neuroscience' posts

Seahawks’ Blitz and Dr. Bowen Demystify MS

Dr. James Bowen appeared today with Ryan Asdourian, “the man behind the bird” and Seahawks’ mascot Blitz, on the Seattle talk show New Day Northwest to shed some light on common misconceptions about multiple sclerosis (MS).

 

Host Margaret Larson asked Dr. Bowen about myths about MS as part of the program to promote this year’s Walk MS events in Seattle. Ryan Asdourian is proof of the full life many people lead with MS, rallying fans at Seahawks games and raising MS awareness as an active advocate for the National Multiple Sclerosis Society.

 

You can check out the video from KING5 TV’s website below. Find out more about how to join or donate to the Swedish S’myelin Strider’s Walk MS team at www.swedish.org/MS.

How much tremor is too much?

Tremor is a normal physiologic reaction to anxiety or stress, but it is not normal to have a tremor when performing typical daily activities.

People who develop a tremor while eating, drinking, writing or doing other common activities may have a movement disorder called Essential Tremor. This is actually the most common movement disorder, and can affect up to 4% of people over age 40. People who have this disorder can take medications to help minimize the tremor, but they don't often reduce the tremor by more than about half. Deep brain stimulation (DBS) is an excellent treatment option for people with severe tremor, and can nearly eliminate the tremor in many patients. Many patients aren't sure when their tremor is severe enough to warrant surgery, and much of our conversation in the office is to help answer this question.

There is no one answer that is right for everyone, but for me it has to do with how well someone is actually doing in their daily life:

New considerations given about when to refer for Deep Brain Stimulation

Every year in the fall, our Swedish DBS Team has a table in the exhibit area at the Hope Conference for Parkinson's Disease. It is a wonderful opportunity to meet people in the PD community, and spend time chatting with our other neuroscience colleagues from centers in the area.

I am always surprised by the numbers of people who come by and say, “I am not ready, my disease is not bad enough, I am too young, or I haven't had PD long enough”...

Swedish Offers New Treatment for Glioblastoma Brain Tumors

SEATTLE, Feb. 6, 2013 – Swedish Neuroscience Institute has added a new and innovative therapy to its treatment arsenal for glioblastoma multiforme (GBM) – a very aggressive and difficult to control brain tumor.

The Goal of DBS (Deep Brain Stimulation) Surgery

I met with several patients this week to discuss their personal journey to making the decision to pursue DBS surgery. Not surprisingly, they were well educated about their disease and treatment options.

Each patient reminded me that there is a lot of information and misinformation about surgery for movement disorders.

The most important advice I can give any patient or family is...

Deciding to have Deep Brain Stimulation (DBS) for PD, ET, or dystonia

Choosing to undergo elective deep brain stimulation (DBS) surgery is a big deal.

I have walked through the process with hundreds of patients over the past 10 years and see many struggle with the choice to undergo brain surgery, as they seek to improve their quality of life. Many people have adapted to compensate for the movement disorder with creativity and determination.

In spite of this, after the best medical options have been exhausted, DBS is increasingly offered as a viable treatment option.

Keys to making the best decision for you are:

Swedish Receives $2.5 Million Grant from the Ivy Foundation to Advance Brain Cancer Research

SEATTLE, Nov. 29, 2012 - Swedish Medical Center announced today that the Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment (Ivy Center) will receive an additional $2.5 million grant from the Ben & Catherine Ivy Foundation (Ivy Foundation). The grant, the second received from the Ivy Foundation in three years, will be used to identify new drugs with potential for clinical use in brain cancer treatment.

Results 57-63 of 78